<p>Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database</p>-Reference-Cited by-同舟云学术

Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database

Published:2020-01 Issue: Volume:Volume 13 Page:89-98
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Chen Ta-Liang,Lin Chao-Shun^ORCID,Lin Jui-An^ORCID,Yeh Chun-Chieh,Sung Li-Chin^ORCID,Chang Yi-Cheng,Shih Chun-Chuan,Liao Chien-Chang^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study;Journal of Multidisciplinary Healthcare;2024-07

2. A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases;Acta Pharmaceutica Sinica B;2024-05

3. A 24-Week, Multi-Center, Randomized, Open-Label Clinical Trial Comparing the Effects of Xuezhikang and Atorvastatin on Glucose Metabolism in Patients with Dyslipidemia and Prediabetes (XTREME Study): Design of the Study Protocol;Cardiovascular Innovations and Applications;2024

4. Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review;Nutrients;2023-05-12

5. Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patients with T2DM and Dyslipidemia: Study Protocol for a Multicenter Randomized Controlled Trial;Current Vascular Pharmacology;2023-05